Navigation Links
DURECT Corporation Announces First Quarter 2012 Financial Results and Update of Programs
Date:5/3/2012

iver sufentanil to chronic pain sufferers for a period of up to 7 days from a single application; this compares favorably against existing fentanyl patches which are substantially larger and typically effective for 2-3 days.  ELADUR, for topical neuropathic conditions such as post-herpetic neuralgia (PHN), is our proprietary transdermal patch intended to deliver bupivacaine for a period of up to three days from a single application; existing lidocaine patches for this condition can be worn for 12 hours with a rest period of 12 hours during which time many patients experience breakthrough pain.  Pfizer's termination of the ELADUR collaboration in the first quarter of 2012 returns to DURECT the rights to develop and commercialize ELADUR worldwide.  We are in discussions with potential partners regarding licensing development and commercialization rights to these two transdermal programs to which we hold worldwide rights.
  • ORADUR-ADHD Program.  We are developing a drug candidate (ORADUR-ADHD) based on DURECT's ORADUR Technology for the treatment of Attention Deficit Hyperactivity Disorder. This drug candidate is intended to provide once-a-day dosing with added tamper resistant characteristics to address common methods of abuse and misuse of these types of drugs.
    We and Orient Pharma have completed several Phase I pharmacokinetic studies with multiple formulations.  Based on information from those studies, we are continuing to evaluate our lead formulations.  Orient Pharma is our licensee for certain Asian and South Pacific countries, while we retain the rights to the rest of the world.
  • Relday™ (Risperidone Program).  In July 2011, we signed a development and license agreement with Zogenix to develop Relday, a product candidate targeting the antipsychotic market.  Zogenix expects to initiate clinical studies for Relday in patients with schizophrenia in 2012.  Relday is a proprietary
    '/>"/>

  • SOURCE DURECT Corporation
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7

    Related medicine technology :

    1. DURECT Announces Issuance of U.S. Patents Covering ORADUR® Technology
    2. DURECT Corporation Invites You to Join Its Fourth Quarter 2011 Earnings Conference Call
    3. DURECT to Participate in Upcoming Healthcare Conferences
    4. DURECT Announces Top-line Data from BESST (POSIDUR® U.S. Pivotal Phase III Trial)
    5. DURECT Corporation Invites You to Join its Third Quarter 2011 Earnings Conference Call
    6. DURECT Completes Enrollment in Pivotal U.S. Phase III Trial for POSIDUR® (BESST)
    7. DURECT Corporation to Participate in Upcoming Healthcare Conferences
    8. DURECT Corporation Announces Second Quarter 2011 Financial Results and Update of Programs
    9. DURECT Corporation Invites You to Join its Second Quarter 2011 Earnings Conference Call
    10. DURECT to Present at the Jefferies Healthcare Conference
    11. DURECT Announces Resignation of Chief Medical Officer
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:7/30/2015)... , July 30, 2015  Cleveland Clinic President ... 2015 keynote address last month that industry is compelled ... order to gain the efficiencies—and develop the transformational innovations ... Dr. Barsoum,s comments were preceded by Doug Kohrs ... and OMTEC moderator, who stressed that industry must add ...
    (Date:7/30/2015)... N.J. , July 30, 2015  Growth of ... switches as they bring former prescription users to the ... Kline forecasts robust Rx-to-OTC switch activity over ... categories emerging along with many new brands entering the ... occur over the next five years (even those with ...
    (Date:7/30/2015)... , July 30, 2015 ... research report with market overview, trends, DRO ... porter analysis, recent developments, competitive scenario and ... Industry Insight: Biosensors Market Development and Demand ... http://photos.prnewswire.com/prnh/20150727/756778 ) Explore more ...
    Breaking Medicine Technology:Orthopaedic Surgery Reimbursement Shifts to Episode of Care 2Rx-to-OTC Switches -- Game Changers for the U.S. OTC Drugs Market through 2019, Sees Kline 2Rx-to-OTC Switches -- Game Changers for the U.S. OTC Drugs Market through 2019, Sees Kline 3Global Biosensors Market (Size of $12,964 Million in 2014) to Witness 10% CAGR During 2015 - 2020 2Global Biosensors Market (Size of $12,964 Million in 2014) to Witness 10% CAGR During 2015 - 2020 3Global Biosensors Market (Size of $12,964 Million in 2014) to Witness 10% CAGR During 2015 - 2020 4Global Biosensors Market (Size of $12,964 Million in 2014) to Witness 10% CAGR During 2015 - 2020 5
    ... BEIJING , June 17 /PRNewswire-Asia/ -- ... healthcare differed,strikingly in their cardiovascular risk profiles according to new data,presented ... Beijing, China . , , ... Chinese people have the most favorable ...
    ... WASHINGTON , June 16 Tomorrow, the Food and Drug Administration (FDA) will ... ulipristal acetate, as an emergency contraceptive, or a new "Plan B." , ... (Logo: http://photos.prnewswire.com/prnh/20080930/FRCLOGO ) , , ... , , , ...
    Cached Medicine Technology:Ethnicity Key Factor in Determining Cardiovascular Risk Profile 2Ethnicity Key Factor in Determining Cardiovascular Risk Profile 3FRC Urges FDA to Reject New Abortion Drug Falsely Labeled as an Emergency Contraceptive 2
    (Date:7/31/2015)... ... July 31, 2015 , ... Florida ... novel catheter that was developed for targeted delivery of fluids to selected sites ... treated at Florida Hospital Tampa with the device that provides direct, local delivery ...
    (Date:7/31/2015)... ... July 31, 2015 , ... Ticket Down is a ... Birmingham. The U.S. Women's National Soccer Team will face the Australia Women's National Team ... September 17th at Ford Field in Detroit and the second match will occur in ...
    (Date:7/31/2015)... ... July 31, 2015 , ... Indosoft, Inc., is pleased to announce a major ... is their flagship contact center ACD system for Asterisk-based call centers . The ... the script components to the agent only when wanted, and allows for validation of ...
    (Date:7/31/2015)... ... July 31, 2015 , ... ... a contributor for LeadingAge’s Center for Aging Services Technologies (CAST) Medication Management Technologies ... long-term and post-acute care providers understand the benefits of using medication management ...
    (Date:7/31/2015)... ... July 31, 2015 , ... ... Karmanos Center for Natural Birth . The Karmanos Center for Natural ... natural childbirth experience. With nurses and caregivers that are trained in holistic birth ...
    Breaking Medicine News(10 mins):Health News:Florida Hospital Tampa Expands Treatment Options for Patients with Pancreatic Cancer Using New Catheter Technology 2Health News:Florida Hospital Tampa Expands Treatment Options for Patients with Pancreatic Cancer Using New Catheter Technology 3Health News:Florida Hospital Tampa Expands Treatment Options for Patients with Pancreatic Cancer Using New Catheter Technology 4Health News:Cheap USA vs. Australia Tickets at Legion Field in Birmingham, AL: Ticket Down Slashes Ticket Prices for Australia vs. USWNT at Legion Field 2Health News:Q-Suite 5.9 Adds Validation Tools to Call Center Software Agent Screen 2Health News:LeadingAge Selects Eldermark Case Study to Highlight Medication Error Reduction Results 2Health News:LeadingAge Selects Eldermark Case Study to Highlight Medication Error Reduction Results 3
    ... Calgary sports epidemiologist Dale Butterwick, a leader in the field ... registry for catastrophic injuries in pro rodeo to get a ... seriously hurt. ,As of today, says Butterwick, anyone, ... a catastrophic injury. By catastrophic we mean life-changing, losing a ...
    ... determined to hang on to his less-and-less-government stance . ... bipartisan plan to expand the Childrens Health Insurance Program. ... Democratic majority in Congress, with a substantial number of Republican ... to expand the popular program to cover some of the ...
    ... another disappointing find in the search for a device to ... Padian, executive director of the UCSF Women's Global Health Imperative, ... with the male condom is in no way superior to ... team, also part of the Methods for Improving Reproductive Health ...
    ... School of Engineering have uncovered a missing link in ... its famous double helix shape . ... mechanical engineering at Duke said that the first direct ... that wind around each other in pairs to form ...
    ... 16 boosts the risk of developing Type 1 diabetes, according ... . ,Three variants of a gene called KIAA0350 ... 563 patients with Type 1 diabetes, which were compared to ... Nature. ,Type 1 diabetes occurs when the immune ...
    ... study has examined whether a vaccine that offers only partial ... false sense of security could make recipients less careful than ... at the response to Lyme disease vaccination, its authors suggest ... girls should receive the HPV vaccine to fight cervical cancer. ...
    Cached Medicine News:Health News:Rounding Up Rodeo Injuries Helps in Prevention 2Health News:President Bush Not for Expansion of Child Health Insurance 2Health News:Diaphragms offer no extra protection Against HIV 2Health News:This is Why DNA Has Its Famous Helix Shape 2Health News:Efficacy of Lyme Disease Vaccination Examined 2
    ... The Maxxis™ 300 is a healthcare ... safety for individuals in the home care ... 600 lbs.(or combined weight of 2) ... depending on frame size selected, ,CONTRAINDICATIONS: ...
    EC+ Extra Care Bariatric Bed...
    ... Excel Care ES bed is especially designed ... empowered, while protecting the caregivers who manage them. ... the most routine tasks pulling up in ... to caregivers and disheartening for patients. Excel Care ...
    ... Disposable Prefilled 28%-100% FIO 2 500ML 0.45% ... nebulizers provide unmatched performance and ease of use. ... adjustable from 28% to 100% FIO 2 . ... water for inhalation, USP; 0.45% sodium chloride inhalation, ...
    Medicine Products: